Abbott Laboratories Gains Momentum with Key Regulatory Approval

Abbott Laboratories US0028241000

Shares of medical device leader Abbott Laboratories opened the week on stable footing following a significant regulatory achievement. The company has secured U.S. Food and Drug Administration (FDA) and European approvals for its “Amplatzer Piccolo Delivery System,” a device designed to treat a life-threatening heart condition in premature infants. This milestone reinforces the strength of Abbott’s specialized portfolio within the pediatric cardiology market.